Clinical Trial Update: Pilot Study of Open-label Placebo to Treat Major Depressive Disorder [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 open-label pilot study evaluating open-label placebo as a treatment for Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Open-label placebo (open-label placebo)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2013-01-14